News
IWK Packaging Systems Introduces Two Cost-Effective, Versatile Vertical Cartoners for Pharma & Personal Care Applications
IWK Packaging Systems, Inc., a manufacturer of premium cartoning and tube filling equipment for the pharmaceuticals and health & beauty sectors, has introduced a pair of versatile vertical cartoners – one intermittent, one continuous – that provide premium cartoning...
News
Pfizer Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and Therapeutics
Pfizer Inc. and Acuitas Therapeutics, a company focused on developing lipid nanoparticle (LNP) delivery systems to enable messenger RNA (mRNA)-based therapeutics, announced they have entered into a Development and Option agreement under which Pfizer will have the option to...
Drug Research
AstraZeneca and Neurimmune sign exclusive global collaboration and licence agreement to develop and commercialise NI006
Alexion, AstraZeneca’s Rare Disease group, has entered into an exclusive global collaboration and licence agreement with Neurimmune AG for NI006, an investigational human monoclonal antibody currently in Phase Ib development for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM). NI006...
News
Second Booster Up’s Antibodies Five Times- Israeli Study
According to Naftali Bennett, the Israeli Prime Minister, as per preliminary findings in an Israeli study, a fourth COVID-19 jab can shoot-up antibodies five times, a week after the shot is administered. At the Sheba Medical Center, Bennett said...
News
Wealthy Fail The World By Not Providing COVID-19 Jab Access
As per Amnesty International, both Pharma companies, as well as wealthy states of the world, have failed miserably to ensure that everyone has equal access to vaccines which has left billions without the medicines that can save lives. There...
News
Australia Injects $5.5 M To Heal Low Survival Breast Cancers
In a development that gives a big sigh of relief to the breast cancer fraternity, funding of a couple of clinical trials which could save lives with the help of new therapies, has been done, all thanks to Australia’s...
News
ICRA Sees Growth In Indian Pharma Industry By 9-11% In FY22
Driven by the push from emerging as well as domestic markets in the upcoming quarters, the Indian Pharma industry in the Financial Year-22 is expected to be pegged at 9-11 percent, says credit rating agency, ICRA. ICRA’s sample of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read